Using a multiplexed immunosensor, galectin-1 was found to be increased in invasive bladder cancer cell lysates, suggesting its potential as a biomarker for distinguishing different bladder cancer grades [57]. This evidence concerns the gene LGALS1 and urinary bladder carcinoma.